J Chest Surg.  2021 Feb;54(1):2-8. 10.5090/kjtcs.21.001.

Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Expert Recommendations from The Korean Society for Thoracic and Cardiovascular Surgery

• Jeong IS
• Kim WH
• Baek JH
• Choi CH
• Choi CW
• Chung ES
• Jang JS
• Jang WS
• Jung H
• Jung JS
• Kang PJ
• Kim DJ
• Kim DW
• Kim HS
• Kim JB
• Kim WS
• Kim YS
• Kwak JG
• Lee H
• Lee SI
• Lim JW
• Oh SJ
• Oh TH
• Park CS
• Ryu KM
• Shim MS
• Son J
• Son KH
• Song S
• on behalf of The Korean Society for Thoracic and Cardiovascular Surgery COVID-19 ECMO Task Force Team

• KMID: 2512651
• DOI: http://doi.org/10.5090/kjtcs.21.001

Abstract

Since the first reported case of coronavirus disease 2019 (COVID-19) in December 2019, the numbers of confirmed cases and deaths have continued to increase exponentially despite multi-factorial efforts. Although various attempts have been made to improve the level of evidence for extracorporeal membrane oxygenation (ECMO) treatment over the past 10 years, most experts still hesitate to take an active position on whether to apply ECMO in COVID-19 patients. Several ECMO management guidelines have been published recently, but they reflect some important differences from the Korean medical system and aspects of real-world medical practice in Korea. We aimed to find evidence on the efficacy of ECMO for COVID-19 patients by reviewing the published literature and to propose expert recommendations by analyzing the Korean COVID-19 ECMO registry data.

Keyword

Extracorporeal membrane oxygenation; COVID-19; Pandemics; Acute respiratory distress syndrome; Cardiogenic shock